Gerdemann A, Cramer B, Degen GH, Veerkamp J, Gnther G, Albrecht W, Behrens M, Esselen M, Ghallab A, Hengstler JG, Humpf H-U (2023) Comparative metabolism of aflatoxin B1 in mouse, rat and human primary hepatocytes using HPLCMS/MS
INH is a prodrug that enters the Mtb cytoplasm via passive diffusion, where it inhibits mycolic acid synthesis by targeting the InhA enzyme, an essential catalyst in an early step of the mycolic acid biosynthetic pathway (Mitchison, 1956)
Cell Metab 31:1315 Doll S, Freitas FP, Shah R, Aldrovandi M, da Silva MC, Ingold I et al (2019) FSP1 is a glutathione-independent ferroptosis suppressor
Some researchers find their optimal response at 1.0 mg or 1.7 mg
Conclusions This real-world health economic evaluation along with a comprehensive systematic review suggest that the use of a GLP-1RA versus insulin has a high likelihood of being cost-effective for T2D patients who require intensified injection therapy from a third-party payer, healthcare sector, and societal perspectives